RESOLUTE ONYX China RCT Study
NCT: NCT03466151 · ACTIVE_NOT_RECRUITING
NCT IDNCT03466151
StatusACTIVE_NOT_RECRUITING
Start Date2018-04-12
Completion2026-07-31
Brief Summary
It is a randomized controlled trial to evaluate the safety and efficacy of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in comparison with the Medtronic Resolute Integrity™ Zotarolimus-Eluting coronary stent system in the treatment of subjects eligible for percutaneous transluminal coronary angioplasty (PTCA) in China.
Frequently Asked Questions
What is RESOLUTE ONYX China RCT Study?
RESOLUTE ONYX China RCT Study is a clinical trial registered under NCT03466151. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03466151?
The current status of NCT03466151 (RESOLUTE ONYX China RCT Study) is: ACTIVE_NOT_RECRUITING.
When did RESOLUTE ONYX China RCT Study start?
RESOLUTE ONYX China RCT Study started on 2018-04-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.